More on ANRO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-15.4% Growth)
- Ratings (8.5 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alto Neuroscience (NY:ANRO)
Delayed: 27.87 +1.09 (4.07%)
Prev. Close $26.78  
Open$26.63 
52 Wk High$ 
52 Wk Low$ 
Day High$28.32 
Day Low$26.47 
P/E N/A  
EPS$ 
Volume499,762 

Friends, Peers and Foes (?): LAZR, REPL, RXST, CERE, RAPP (more...)

Jul 27, 2026 04:27 PM Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: BlackRock, Inc.
Jul 20, 2026 05:11 PM Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: EcoR1 Capital, LLC
Jul 14, 2026 06:05 AM Form 8-K Alto Neuroscience, Inc. For: Jul 13
Jul 14, 2026 06:04 AM Form 424B5 Alto Neuroscience, Inc.
Jul 13, 2026 07:47 AM Alto Neuroscience prices $100M stock offering to fund depression trial
Jul 13, 2026 07:47 AM Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
Jul 13, 2026 07:39 AM Form 8-K Alto Neuroscience, Inc. For: Jul 13
Jun 17, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)
Jun 15, 2026 08:03 AM Alto Neuroscience cites study showing pramipexole reduces anhedonia
Jun 15, 2026 08:03 AM Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
View All Articles

Entities mentioned with ANRO

View All Entities